Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonobstructive Hypertrophic Cardiomyopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01150461
What this trial is testing

Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
Massachusetts General Hospital 20
Large-scale testing (Phase 3)Study completedNCT03723655
What this trial is testing

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

Who this might be right for
Hypertrophic CardiomyopathyObstructive Hypertrophic CardiomyopathyNon-obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb 314
Not applicableLooking for participantsNCT05818605
What this trial is testing

Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
University of California, San Francisco 70
Testing effectiveness (Phase 2)UnknownNCT01696370
What this trial is testing

Trimetazidine Therapy in Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy
University College, London 90
Post-approval studies (Phase 4)Looking for participantsNCT05569382
What this trial is testing

Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Non-obstructive Hypertrophic Cardiomyopathy
Morten Steen Kvistholm Jensen 100
Large-scale testing (Phase 3)Active Not RecruitingNCT06481891
What this trial is testing

Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

Who this might be right for
Obstructive Cardiomyopathy, HypertrophicNon-obstructive Hypertrophic Cardiomyopathy
Lexicon Pharmaceuticals 500
Testing effectiveness (Phase 2)Study completedNCT03953989
What this trial is testing

Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy

Who this might be right for
HCM - Hypertrophic Non-Obstructive Cardiomyopathy
IRCCS San Raffaele 26
Post-approval studies (Phase 4)Looking for participantsNCT06580717
What this trial is testing

ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy

Who this might be right for
Nonobstructive Hypertrophic Cardiomyopathy
Yonsei University 200
Testing effectiveness (Phase 2)Looking for participantsNCT05836259
What this trial is testing

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

Who this might be right for
Hypertrophic Cardiomyopathy
Tenaya Therapeutics 30